Technology >> CEO Interviews >> February 18, 2002
CARLTON J. EIBL joined Maxwell Technologies, Inc., as President and
Chief Executive Officer in December 1999, after serving as an
independent member of the company's Board of Directors since 1998. From
February 1999 until he joined Maxwell, he was President and a Director
of Stratagene Corporation, a privately held developer and supplier of
laboratory instruments and biological tools to the life science
industry. Previously, he was President and Chief Executive of Mycogen
Corporation, a publicly held agricultural biotechnology company that was
acquired by Dow Chemical in November 1998. Profile
of Maxwell Technologies, Inc., at the present time?
Mr. Eibl: At the beginning of 2000, we brought in a new management
